A detailed history of Landmark Financial Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Landmark Financial Advisors, LLC holds 6,600 shares of MRK stock, worth $653,070. This represents 0.26% of its overall portfolio holdings.

Number of Shares
6,600
Previous 6,700 1.49%
Holding current value
$653,070
Previous $689,000 4.35%
% of portfolio
0.26%
Previous 0.29%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $10,018 - $10,902
-100 Reduced 1.49%
6,600 $719,000
Q3 2023

Oct 13, 2023

SELL
$102.95 - $114.33 $10,295 - $11,433
-100 Reduced 1.47%
6,700 $689,000
Q1 2023

Apr 13, 2023

SELL
$102.94 - $114.86 $22,646 - $25,269
-220 Reduced 3.13%
6,800 $723,000
Q3 2022

Nov 10, 2022

SELL
$84.53 - $94.96 $13,017 - $14,623
-154 Reduced 2.15%
7,020 $605,000
Q2 2022

Aug 03, 2022

SELL
$83.49 - $94.64 $44,082 - $49,969
-528 Reduced 6.86%
7,174 $654,000
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $33,300 - $37,327
453 Added 6.25%
7,702 $658,000
Q4 2021

Jan 26, 2022

BUY
$72.28 - $90.54 $116,659 - $146,131
1,614 Added 28.64%
7,249 $556,000
Q1 2021

May 11, 2021

SELL
$68.86 - $81.11 $15,631 - $18,411
-227 Reduced 3.87%
5,635 $434,000
Q2 2020

Jul 17, 2020

SELL
$70.42 - $80.13 $11,196 - $12,740
-159 Reduced 2.64%
5,862 $466,000
Q4 2019

Feb 12, 2020

BUY
$77.58 - $87.54 $1,241 - $1,400
16 Added 0.27%
6,021 $533,000
Q3 2019

Nov 07, 2019

SELL
$76.08 - $82.93 $9,129 - $9,951
-120 Reduced 1.96%
6,005 $505,000
Q3 2018

Nov 07, 2018

BUY
$57.69 - $67.84 $19,153 - $22,522
332 Added 5.73%
6,125 $434,000
Q4 2017

Feb 13, 2018

SELL
$51.62 - $61.64 $15,486 - $18,492
-300 Reduced 4.92%
5,793 $325,000
Q2 2017

Aug 11, 2017

BUY
N/A
6,093
6,093 $390,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Landmark Financial Advisors, LLC Portfolio

Follow Landmark Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Landmark Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Landmark Financial Advisors, LLC with notifications on news.